The company reported it has already simulated more than 350 trials with up to 90 percent accuracy.

The therapy inhibited up to 97% of pancreatic cancer cells and nearly 90% of colorectal cancer cells.

In a recent study involving about 800 patients, the drug reduced the risk of infection by an impressive 58%.

If RedC Biotech is successful, hospitals will no longer depend on blood donations but will be able to buy blood on-demand as a pharmaceutical product.

Fledgling high-tech sector is advancing women's needs.

The new AI-based technology is better than doctors at choosing the right embryo for successful IVF implants.

Tel Aviv company Embryonics will use the artificial intelligence methods it uses to optimize IVF in the fight against the coronavirus.

Researchers at Hebrew University, working with scientists at the Massachusetts Institute of Technology, have developed a special protein designed to attack cancer cells.